-
Session 3: Globalization—The Philippines as a Model for Equitable Cancer Care Delivery in a Low-Resource Setting
Done
-
PLENARY SESSION 2.1 Immunotherapy: What’s New Beyond PD-1 — CAR-T Cell Therapy
Done
-
PLENARY SESSION 5.3 Bladder Preservation MDT
Done
-
WORKSHOP LECTURE 3
Done
-
BREAKDone
-
PLENARY SESSION 1.1 :Cancer Genomics Beyond the Basics
Done
-
LUNCHDone
-
Beyond Surgery & Chemotherapy: Navigating First-line Maintenance Treatment in Ovarian Cancer
Done
-
DINNER SYMPOSIUM Bridging Evidence to Practice in HR+/HER2- Early Breast Cancer; The Role of CDK4/6i in the Treatment and Management of Early Breast Cancer
Done
-
BOOTH EXHIBIT AND RESEARCH POSTER VISITDone
From Clinical Evidence to Consultation Room: Optimizing Abemaciclib Therapy in High-Risk Early and Advanced HR+/HER2- Breast Cancer
10/7/26, 12:00 PM
-
10/7/26, 1:00 PM
(Asia/Manila)
(1 hour)
Speakers: Nick Zdenkowski, MD
Rubi K. Li, MD
Ellie May B. Villegas, MD
Moderator: Ma. Pamela D. Patdu, MD
Sponsor: Zuellig